Liquid biopsies, tests that rely on ordinary blood draw to detect cancer mutations in DNA fragments, will allow physicians to identify nearly all types of cancer mutations, either inside cells or floating in the bloodstream. These tests are made possible through advances in human genome sequencing and could lead to earlier detection of cancers. You can read more about liquid biopsies here.
Last Updated on May 7, 2020 by Aimed Alliance
